Literature DB >> 11532581

Thiolated polymers: synthesis and in vitro evaluation of polymer-cysteamine conjugates.

A Bernkop-Schnürch1, A E Clausen, M Hnatyszyn.   

Abstract

The purpose of the present study was to synthesize and characterize novel thiolated polymers. Mediated by a carbodiimide cysteamine was covalently linked to sodium carboxymethylcellulose (CMC) and polycarbophil (PCP). The resulting CMC-cysteamine conjugates displayed 77.9+/-6.7 and 365.1+/-8.7 micromol thiol groups per gram of polymer, whereas the PCP-cysteamine conjugates showed 26.3+/-1.9 and 122.7+/-3.8 micromol thiol groups per gram of polymer (mean+/-S.D.; n=3). In aqueous solutions above pH 5.0 both modified polymers were capable of forming inter- and/or intra-molecular disulfide bonds. The reaction velocity of this oxidation process was accelerated with a decrease in the proton concentration. The oxidation proceeded more rapidly within thiolated CMC than within thiolated PCP. Permeation studies carried out in Ussing-type chambers with freshly excised intestinal mucosa from guinea pigs utilizing sodium fluorescein as model drug for the paracellular uptake revealed an enhancement ratio (R=P(app) (conjugate)/P(app) (control)) of 1.15 and 1.41 (mean+/-S.D.; n=3) for the higher thiolated CMC-cysteamine (0.5%; m/v) and PCP-cysteamine conjugate (1.0%; m/v), respectively. The decrease in the transepithelial electrical resistance values was in good correlation with the enhancement ratios. Due to a high crosslinking tendency by the formation of disulfide bonds stabilizing drug carrier systems based on thiolated polymers and a permeation enhancing effect, CMC- and PCP-cysteamine conjugates represent promising excipients for the development of novel drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532581     DOI: 10.1016/s0378-5173(01)00807-9

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Synthesis of thiolated alginate and evaluation of mucoadhesiveness, cytotoxicity and release retardant properties.

Authors:  A B Jindal; M N Wasnik; Hema A Nair
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

Review 2.  Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements.

Authors:  Rabia Arshad; Maria Hassan Kiani; Abbas Rahdar; Saman Sargazi; Mahmood Barani; Shirin Shojaei; Muhammad Bilal; Deepak Kumar; Sadanand Pandey
Journal:  Bioengineering (Basel)       Date:  2022-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.